EML4-ALK: Honing In on a New Target in Non-Small-Cell Lung Cancer

被引:250
作者
Horn, Leora [1 ]
Pao, William [1 ]
机构
[1] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
关键词
GROWTH-FACTOR RECEPTOR; ACTIVATING MUTATIONS; FUSION GENE; ALK KINASE; KRAS MUTATIONS; NEVER SMOKERS; PHASE-III; NPM-ALK; GEFITINIB; IDENTIFICATION;
D O I
10.1200/JCO.2009.23.6661
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4232 / 4235
页数:4
相关论文
共 35 条
  • [1] Oncogenic mutations of ALK kinase in neuroblastoma
    Chen, Yuyan
    Takita, Junko
    Choi, Young Lim
    Kato, Motohiro
    Ohira, Miki
    Sanada, Masashi
    Wang, Lili
    Soda, Manabu
    Kikuchi, Akira
    Igarashi, Takashi
    Nakagawara, Akira
    Hayashi, Yasuhide
    Mano, Hiroyuki
    Ogawa, Seishi
    [J]. NATURE, 2008, 455 (7215) : 971 - U56
  • [2] Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer
    Choi, Young Lim
    Takeuchi, Kengo
    Soda, Manabu
    Inamura, Kentaro
    Togashi, Yuki
    Hatano, Satoko
    Enomoto, Munehiro
    Hamada, Toru
    Haruta, Hidenori
    Watanabe, Hideki
    Kurashina, Kentaro
    Hatanaka, Hisashi
    Ueno, Toshihide
    Takada, Shuji
    Yamashita, Yoshihiro
    Sugiyama, Yukihiko
    Ishikawa, Yuichi
    Mano, Hiroyuki
    [J]. CANCER RESEARCH, 2008, 68 (13) : 4971 - 4976
  • [3] Inflammatory myofibroblastic tumor - Comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases
    Coffin, Cheryl M.
    Hornick, Jason L.
    Fletcher, Christopher D. M.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (04) : 509 - 520
  • [4] Somatic mutations affect key pathways in lung adenocarcinoma
    Ding, Li
    Getz, Gad
    Wheeler, David A.
    Mardis, Elaine R.
    McLellan, Michael D.
    Cibulskis, Kristian
    Sougnez, Carrie
    Greulich, Heidi
    Muzny, Donna M.
    Morgan, Margaret B.
    Fulton, Lucinda
    Fulton, Robert S.
    Zhang, Qunyuan
    Wendl, Michael C.
    Lawrence, Michael S.
    Larson, David E.
    Chen, Ken
    Dooling, David J.
    Sabo, Aniko
    Hawes, Alicia C.
    Shen, Hua
    Jhangiani, Shalini N.
    Lewis, Lora R.
    Hall, Otis
    Zhu, Yiming
    Mathew, Tittu
    Ren, Yanru
    Yao, Jiqiang
    Scherer, Steven E.
    Clerc, Kerstin
    Metcalf, Ginger A.
    Ng, Brian
    Milosavljevic, Aleksandar
    Gonzalez-Garay, Manuel L.
    Osborne, John R.
    Meyer, Rick
    Shi, Xiaoqi
    Tang, Yuzhu
    Koboldt, Daniel C.
    Lin, Ling
    Abbott, Rachel
    Miner, Tracie L.
    Pohl, Craig
    Fewell, Ginger
    Haipek, Carrie
    Schmidt, Heather
    Dunford-Shore, Brian H.
    Kraja, Aldi
    Crosby, Seth D.
    Sawyer, Christopher S.
    [J]. NATURE, 2008, 455 (7216) : 1069 - 1075
  • [5] Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib
    Eberhard, DA
    Johnson, BE
    Amler, LC
    Goddard, AD
    Heldens, SL
    Herbst, RS
    Ince, WL
    Jänne, PA
    Januario, T
    Johnson, DH
    Klein, P
    Miller, VA
    Ostland, MA
    Ramies, DA
    Sebisanovic, D
    Stinson, JA
    Zhang, YR
    Seshagiri, S
    Hillan, KJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 5900 - 5909
  • [6] EML4-ALK fusion transcript is not found in gastrointestinal and breast cancers
    Fukuyoshi, Y.
    Inoue, H.
    Kita, Y.
    Utsunomiya, T.
    Ishida, T.
    Mori, M.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 98 (09) : 1536 - 1539
  • [7] Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK
    Galkin, Anna V.
    Melnick, Jonathan S.
    Kim, Sungjoon
    Hood, Tami L.
    Li, Nanxin
    Li, Lintong
    Xia, Gang
    Steensma, Ruo
    Chopiuk, Greg
    Jiang, Jiqing
    Wan, Yongqin
    Ding, Peter
    Liu, Yi
    Sun, Fangxian
    Schultz, Peter G.
    Gray, Nathanael S.
    Warmuth, Markus
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (01) : 270 - 275
  • [8] Activating mutations in ALK provide a therapeutic target in neuroblastoma
    George, Rani E.
    Sanda, Takaomi
    Hanna, Megan
    Frohling, Stefan
    Luther, William, II
    Zhang, Jianming
    Ahn, Yebin
    Zhou, Wenjun
    London, Wendy B.
    McGrady, Patrick
    Xue, Liquan
    Zozulya, Sergey
    Gregor, Vlad E.
    Webb, Thomas R.
    Gray, Nathanael S.
    Gilliland, D. Gary
    Diller, Lisa
    Greulich, Heidi
    Morris, Stephan W.
    Meyerson, Matthew
    Look, A. Thomas
    [J]. NATURE, 2008, 455 (7215) : 975 - 978
  • [9] EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers
    Inamura, Kentaro
    Takeuchi, Kengo
    Togashi, Yuki
    Nomura, Kimie
    Ninomiya, Hironori
    Okui, Michiyo
    Satoh, Yukitoshi
    Okumura, Sakae
    Nakagawa, Ken
    Soda, Manabu
    Choi, Young Lim
    Niki, Toshiro
    Mano, Hiroyuki
    Ishikawa, Yuichi
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (01) : 13 - 17
  • [10] EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset
    Inamura, Kentaro
    Takeuchi, Kengo
    Togashi, Yuki
    Hatano, Satoko
    Ninomiya, Hironori
    Motoi, Noriko
    Mun, Ming-yon
    Sakao, Yukinori
    Okumura, Sakae
    Nakagawa, Ken
    Soda, Manabu
    Choi, Young Lim
    Mano, Hiroyuki
    Ishikawa, Yuichi
    [J]. MODERN PATHOLOGY, 2009, 22 (04) : 508 - 515